Rock Springs Capital Management LP Upped Pacira Pharmaceuticals (PCRX) Holding By $1.68 Million; 2 Analysts Bullish Johnston Press plc (LON:JPR)

January 14, 2018 - By Migdalia James

Among 5 analysts covering Johnston Press PLC (LON:JPR), 2 have Buy rating, 1 Sell and 2 Hold. Therefore 40% are positive. Johnston Press PLC had 55 analyst reports since August 11, 2015 according to SRatingsIntel. The company was maintained on Thursday, August 13 by Citigroup. Panmure Gordon maintained Johnston Press plc (LON:JPR) on Thursday, August 4 with “Buy” rating. Peel Hunt maintained the shares of JPR in report on Monday, November 14 with “Reduce” rating. On Wednesday, March 23 the stock rating was maintained by Peel Hunt with “Reduce”. The company was maintained on Tuesday, March 22 by Panmure Gordon. The rating was maintained by Liberum Capital with “Buy” on Wednesday, March 29. The stock of Johnston Press plc (LON:JPR) earned “Buy” rating by Liberum Capital on Friday, February 3. On Thursday, August 4 the stock rating was maintained by Peel Hunt with “Reduce”. The stock of Johnston Press plc (LON:JPR) earned “Reduce” rating by Peel Hunt on Friday, March 4. On Monday, October 9 the stock rating was maintained by Liberum Capital with “Buy”. See Johnston Press plc (LON:JPR) latest ratings:

06/12/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 80.00 New Target: GBX 80.00 Maintain
02/11/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 80.00 New Target: GBX 80.00 Maintain
09/10/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 80.00 New Target: GBX 80.00 Maintain
02/08/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 80.00 New Target: GBX 80.00 Maintain

Rock Springs Capital Management Lp increased Pacira Pharmaceuticals Inc (PCRX) stake by 4.36% reported in 2017Q3 SEC filing. Rock Springs Capital Management Lp acquired 45,500 shares as Pacira Pharmaceuticals Inc (PCRX)’s stock rose 10.53%. The Rock Springs Capital Management Lp holds 1.09M shares with $40.85 million value, up from 1.04 million last quarter. Pacira Pharmaceuticals Inc now has $1.68B valuation. The stock decreased 1.72% or $0.72 during the last trading session, reaching $41.5. About 1.03M shares traded or 26.65% up from the average. Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has risen 12.40% since January 14, 2017 and is uptrending. It has underperformed by 4.30% the S&P500.

The stock decreased 4.00% or GBX 0.4 during the last trading session, reaching GBX 9.6. About 40,805 shares traded. Johnston Press plc (LON:JPR) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Johnston Press plc provides news, information, and marketing services to local and regional communities and businesses in the United Kingdom. The company has market cap of 10.11 million GBP. The firm operates through Publishing and Contract Printing divisions. It currently has negative earnings. The Company’s portfolio includes 13 daily, 154 weekly paid-for, and 37 weekly free newspapers; various monthly lifestyle magazines; specialist local publications; 215 local, e-commerce, and mobile Websites; and 31 tablet and Smartphone apps.

Rock Springs Capital Management Lp decreased Galapagos Nv stake by 7,500 shares to 214,000 valued at $21.78 million in 2017Q3. It also reduced Ascendis Pharma A S stake by 45,000 shares and now owns 280,000 shares. Madrigal Pharmaceuticals Inc was reduced too.

Since August 15, 2017, it had 0 insider buys, and 4 insider sales for $1.23 million activity. HASTINGS PAUL J sold 1,044 shares worth $37,741. $1.05 million worth of stock was sold by STACK DAVID M on Tuesday, August 15. $14,858 worth of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) shares were sold by Riker Lauren Bullaro. Shares for $127,192 were sold by Williams Kristen Marie on Tuesday, August 15.

Investors sentiment decreased to 1.39 in 2017 Q3. Its down 0.23, from 1.62 in 2017Q2. It turned negative, as 35 investors sold PCRX shares while 37 reduced holdings. 29 funds opened positions while 71 raised stakes. 41.63 million shares or 5.80% more from 39.35 million shares in 2017Q2 were reported. Oak Ridge Ltd Liability Company accumulated 359,058 shares. Moreover, Wells Fargo Mn has 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) for 121,585 shares. Rice Hall James & Assocs Limited Liability Company has invested 0.45% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Amer International Gp Incorporated stated it has 26,346 shares. 403,774 were reported by Goldman Sachs Gp. 11 were accumulated by Patten Grp Inc Inc. Advisory Services Ntwk Ltd accumulated 0% or 170 shares. Td Mngmt Limited Liability Corporation reported 75 shares. Plante Moran Financial Advsrs Ltd Liability Corporation stated it has 0.01% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Oppenheimer Asset Inc invested 0.01% of its portfolio in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Samlyn Cap Lc owns 372,269 shares. Bessemer Gru invested in 362 shares. Epoch Inv Ptnrs Inc reported 535,999 shares stake. Rhumbline Advisers has 0% invested in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX). Highbridge Capital Management Ltd has invested 0.11% in Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.